PIXIUM VISION | Love is No Longer Blind | Corporate, FV EUR4.1 initiation of coverage
PIXIUM VISION | Love is No Longer Blind | Corporate, FV EUR4.1 initiation of coveragePixium Vision is a French medtech company positioned in the growing retinal implants market. The group is now fully focused on PRIMA, its most advanced proprietary platform which has the potential to partially restore central vision loss in patients suffering from advanced dry-AMD, a high unmet need with >2m patients suffering from the disease in Europe and the US. The de-risked 6 months interim results from the PRIMA first-in-human (FIH) European study are expected in late 2018 and should be a strong catalyst.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.